| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enliven Therapeutics, Inc. (ELVN) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. ELVN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 7.39M | $441.12M | - | |
| CEO | 890.4K | $53.16M | - | |
| CEO | 875.0K | $52.24M | - | |
| Other | 740.2K | $44.19M | - | |
| COO | 215.3K | $12.85M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2025 | Hohl Benjamin59 | Chief Financial Officer | Sale+OE | 3,000 | $22.55 | $67,655.40 | -11.5% | -9.1% | +110.5% | |
| Jun 9, 2025 | Patel Anish53 | Chief Operating Officer | Sell | 6,667 | $20.34 | $135,574.05 | -1.1% | -1.6% | +77.5% | |
| Jun 3, 2025 | Lyssikatos Joseph P49 | Chief Scientific Officer | Sell | 7,500 | $20.03 | $150,219.75 | -0.8% | -4.4% | +64.8% | |
| Jun 3, 2025 | Kintz Samuel50 | President And CEO | Sell | 7,500 | $20.05 | $150,351.75 | -0.8% | -4.4% | +64.8% | |
| May 27, 2025 | Hohl Benjamin59 | Chief Financial Officer | Sale+OE | 3,250 | $16.18 | $52,593.45 | -12.4% | +24.7% | +159.0% | |
| May 19, 2025 | Lyssikatos Joseph P49 | Chief Scientific Officer | Sell | 5,000 | $16.31 | $81,533.50 | -0.5% | +17.2% | +138.4% | |
| May 19, 2025 | Kintz Samuel50 | President And CEO | Sell | 5,000 | $16.49 | $82,453.00 | -0.5% | +17.2% | +138.4% | |
| May 7, 2025 | Patel Anish53 | Chief Operating Officer | Sell | 6,667 | $18.39 | $122,578.86 | -0.7% | +5.2% | +120.5% | |
| May 2, 2025 | Lyssikatos Joseph P49 | Chief Scientific Officer | Sell | 7,500 | $20.05 | $150,390.64 | -0.4% | -8.3% | +103.3% | |
| May 2, 2025 | Kintz Samuel50 | President And CEO | Sell | 7,500 | $20.06 | $150,415.36 | -0.4% | -8.3% | +103.3% |